Corneal wound healing
Authors: Pr Éric Gabison, M. Cavaillé and C. Tolosa Leal — ophthalmology, cornea & ocular surface. Reference course, original synthesis (2026), grounded in the team's own work.
Introduction & aims
Corneal wound healing closes the wound without compromising transparency or the avascularity of the tissue, which sets it apart from skin repair [1,2].
An injury may involve the epithelium alone, the epithelium + stroma, and more rarely the endothelium (whose regenerative capacity in humans is very limited). The healing response must restore the epithelial barrier, rebuild the stroma and preserve optical clarity, while avoiding three pitfalls: fibrosis (opacity), delayed healing (ulceration, melting) and neovascularization.
The thread of this course is a permanent epithelial–stromal dialogue: it steers repair toward transparent regeneration or toward fibrosis. We follow the physiology (epithelial then stromal repair), the pathological situations (persistent epithelial defect, haze, ulceration and direct epithelial–stromal interactions), then the corneal angiogenic privilege and its breakdown.
Repairing the cornea means winning three bets at once: fast, transparent, vessel-free. The key to the outcome is when the epithelium and its basement membrane reform: while they remain open, stromal signals (TGF-β, PDGF, MMPs) sustain fibrosis and melting [2,3].
Epithelial healing & the barrier
The first step after an epithelial injury is the removal of necrotic cells, aided by the tear film and blinking. Within minutes, edge cells form a migration front and move centripetally at about 60–80 µm/h. The classic kinetics combine a sliding phase (migration, no mitosis) then a proliferation phase restoring epithelial thickness [2,10].
Mechanics of migration
To advance, cells disassemble their hemidesmosomes (integrin α6β4) via metalloproteinases, anchor to the stroma through focal adhesions mediated by integrins (α5β1 for fibronectin), while actin cables linked by adherens junctions drive collective migration. They rely on a provisional matrix rich in fibrin, fibronectin and hyaluronic acid, and on growth-factor flux (EGF, HGF, KGF) partly derived from the underlying stroma — the first illustration of epithelial–stromal coupling [2,4].
Basement membrane: the conductor
Once the basal layer is restored, a new epithelial basement membrane (EBM) is synthesized (laminins 511/521, then perlecan, nidogens, collagen IV) and matures over ~6 weeks. Its reformation is more than anchorage: it regulates cytokine passage to the stroma. In Wilson's model, EBM regeneration is the true switch that ends the TGF-β/PDGF inflow and hence fibrosis [3]. Note that Bowman's layer does not regenerate, with no notable functional consequence.
A healthy basement membrane, adequate vitamin A, good-quality tears and a cornea that keeps its sensation: if any one of these four supports is missing, epithelial closure lags.
Barrier function & tight junctions (occludin)
Beyond healing, the epithelium forms a barrier through its apical tight junctions, of which occludin is a key component. Our work showed that the metalloproteinase inducer EMMPRIN/CD147 regulates surface occludin by modulating MMP-9 expression: an inverse correlation between EMMPRIN and occludin already exists physiologically, along epithelial differentiation (Huet et al., Am J Pathol 2011). CD147 thus emerges as a regulator of epithelial organization, not only a disease player.
Epithelial renewal & limbal stem cells
The epithelium renews continuously from limbal stem cells, following Thoft's “XYZ” scheme: basal proliferation (X), centripetal migration (Y), surface desquamation (Z). The speed of this turnover governs surface homeostasis and the fate of the epithelium after transplantation.
Our work quantified this turnover. Combining corneal impression cytology with FISH on sex-mismatched grafts lets one trace the origin — donor or recipient — of each cell. Across 24 samples (21 grafted patients), mosaicism was found in 13 cases, showing donor-derived cells at the graft centre for at least 211 days; Kaplan–Meier analysis put their median survival at 385 days — over a year (Catanese et al., IOVS 2011).
Contrary to the idea that recipient epithelium quickly replaces the graft, these data show prolonged survival of donor cells — thus slow renewal at the corneal centre — with topical 2% cyclosporine tending to further delay their loss (non-significant trend). Immunomodulation therefore influences post-graft epithelial homeostasis.
Stromal healing: keratocytes, cytokines & myofibroblasts
The stroma makes up most of the corneal thickness; its transparency depends on an orderly collagen array and on the quiescent phenotype of keratocytes. Its healing may be regenerative (transparent) or fibrotic (opaque), and its direction depends directly on re-epithelialization and basement-membrane reformation [3,5].
Three phases of stromal repair
A destruction phase (neutrophils, macrophages, collagenases), a synthesis phase (collagen and proteoglycan deposition by fibroblasts), then a remodeling phase that reorganizes the matrix to recover transparency.
Keratocyte apoptosis & the acellular zone
When the epithelial barrier breaks, epithelial cells release IL-1α/β which, binding neighbouring keratocytes, trigger their apoptosis (relayed by TNF-α, PAF and soluble FasL). A transient acellular zone forms: this redundancy of pro-apoptotic signals is thought to limit stromal (notably viral) invasion and to reduce the pool of future myofibroblasts [6].
From keratocyte to myofibroblast
Surviving keratocytes become fibroblasts (migrating within 24 h), proliferate, then differentiate into myofibroblasts under TGF-β (Smad pathway) and PDGF — factors normally kept away from the stroma by the basement membranes. Some myofibroblasts also arise from circulating bone-marrow fibrocytes [14]. Identified by α-SMA stress fibres, the myofibroblast is strongly contractile, lays down abundant matrix… and scatters light. In humans, maturation takes 1–4 months [5,2].
Epithelium-derived extracellular vesicles (exosomes), when they cross a damaged basement membrane, also contribute to keratocyte-to-myofibroblast conversion [11].
In normal healing, the epithelium and its basement membrane reform before myofibroblast progenitors mature. The resulting TGF-β drop restores IL-1 sensitivity: they undergo apoptosis before producing disorganized matrix. This timing allows opacity-free repair, under an MMP / TIMP balance [5,6].
Glossary of abbreviations used in this course
Scientific abbreviations and acronyms used throughout the 10 pages of this course, listed alphabetically.
No matching term.
- 95% CI
- 95% confidence interval
- AAV
- adeno-associated virus (gene-therapy viral vector)
- ABCG2
- ABCG2 transporter, a limbal stem-cell marker
- AMT
- amniotic membrane transplantation
- anti-VEGF
- anti-angiogenic treatment targeting VEGF
- ASC
- inflammasome adaptor protein (Apoptosis-associated Speck-like protein containing a CARD)
- BrdU
- bromodeoxyuridine, a cell-proliferation marker
- CCL2
- CCL2 chemokine, synonym of MCP-1; recruits circulating monocytes
- CCR2
- receptor for CCL2; marker of newly recruited monocytes/macrophages
- CD147
- cluster of differentiation 147; synonym of EMMPRIN and basigin
- CD163
- M2 macrophage marker; scavenger receptor for haemoglobin-haptoglobin
- CD206
- mannose receptor; marker of M2 polarization
- CD74
- cell-surface receptor for MIF
- CDVA
- corrected distance visual acuity
- CGRP
- calcitonin gene-related peptide
- CTGF
- connective tissue growth factor
- CX3CL1
- fractalkine, a chemokine involved in monocyte/macrophage recruitment
- CXCR2/CXCR4
- chemokine receptors, also receptors for MIF
- DAMP
- damage-associated molecular pattern
- DESI
- direct epithelial–stromal interaction
- EGF
- epidermal growth factor
- EGFR
- epidermal growth factor receptor
- EMMPRIN
- extracellular matrix metalloproteinase inducer; synonym of CD147
- ETDRS
- reference visual-acuity scale used in clinical research (Early Treatment Diabetic Retinopathy Study)
- FasL
- Fas ligand, an apoptosis-inducing protein
- FISH
- fluorescence in situ hybridisation
- GAG
- glycosaminoglycan(s)
- GM-CSF
- granulocyte-macrophage colony-stimulating factor
- GVHD
- graft-versus-host disease
- HGF
- hepatocyte growth factor
- HIF-3α
- hypoxia-inducible factor, 3-alpha subunit
- HMGB1
- high mobility group box 1, an alarmin released by injured cells (DAMP)
- IFN-γ
- interferon gamma
- IGF-1
- insulin-like growth factor 1
- IL-1
- interleukin-1
- iNOS
- inducible nitric oxide synthase
- IPAS
- inhibitory PAS domain protein
- KGF
- keratinocyte growth factor
- LASIK
- laser-assisted in situ keratomileusis
- LogMAR
- logarithmic visual-acuity scale
- LOX
- lysyl oxidase, a collagen cross-linking enzyme
- LPS
- bacterial lipopolysaccharide
- M1
- classically activated macrophage, pro-inflammatory profile
- M2
- alternatively activated macrophage, pro-resolving/reparative profile (subtypes M2a-M2d, M2eff)
- MEN2B
- multiple endocrine neoplasia type 2B
- MerTK
- receptor tyrosine kinase involved in efferocytosis
- MIF
- macrophage migration inhibitory factor
- MRI
- magnetic resonance imaging
- NGF
- nerve growth factor
- NK
- neurotrophic keratitis
- NLRP3
- NLRP3 inflammasome (NOD-, LRP- and pyrin domain-containing protein 3)
- NO
- nitric oxide
- NSAID
- nonsteroidal anti-inflammatory drug
- PACAP
- pituitary adenylate cyclase-activating polypeptide
- PAF
- platelet-activating factor
- PAMP
- pathogen-associated molecular pattern
- PDGF
- platelet-derived growth factor
- PED
- persistent epithelial defect
- PEDF
- pigment epithelium-derived factor
- PGE₂
- prostaglandin E2
- PRK
- photorefractive keratectomy (laser surface ablation)
- pro-NGF
- precursor form of NGF
- RGTA
- matrix-therapy ReGeneraTing Agent, e.g. Cacicol
- rhNGF
- recombinant human NGF (cenegermin)
- ROS
- reactive oxygen species
- Smad
- signalling proteins of the TGF-β pathway
- SPK
- superficial punctate keratitis
- sVEGFR-1
- soluble form of VEGF receptor-1 (= sFlt-1)
- sVEGFR-3
- soluble form of VEGF receptor-3
- TGF-β
- transforming growth factor beta
- TIMP
- tissue inhibitor of metalloproteinases
- TLR
- Toll-like receptor
- TNF-α
- tumour necrosis factor alpha
- TRPV4
- transient receptor potential vanilloid 4, a mechanosensitive ion channel
- uPA
- urokinase-type plasminogen activator
- V1
- ophthalmic branch of the trigeminal nerve
- VEGF
- vascular endothelial growth factor
- VEGF-C
- lymphangiogenic isoform of VEGF
- VIP
- vasoactive intestinal peptide
- YAP/TAZ
- Hippo pathway effectors, mechanosensors of matrix stiffness
- α-SMA
- alpha-smooth muscle actin, a myofibroblast marker